614849 Sigma-AldrichTOPK/PBK Inhibitor, HI-TOPK-032 - CAS 487020-03-1 - Calbiochem
A cell-permeable, selective, ATP competitive, reversible inhibitor of T-LAK-cell-originated protein kinase (IC₅₀ = 2 µM).
More>> A cell-permeable, selective, ATP competitive, reversible inhibitor of T-LAK-cell-originated protein kinase (IC₅₀ = 2 µM). Less<<Synonyms: N-(12-cyanoindolizino[2,3-b]quinoxalin-2-yl)thiophene-2-carboxamide, TOPK Inhibitor, HI-TOPK-032, PBK Inhibitor, HI-TOPK-032
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 487020-03-1 | C₂₀H₁₁N₅OS |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 614849-5MGCN |
|
Glass bottle | 5 mg |
|
— |
| References | |
|---|---|
| References | Kim, D., et al. 2012, Cancer Res. 72, 3060. |
| Product Information | |
|---|---|
| CAS number | 487020-03-1 |
| Form | Rust solid |
| Hill Formula | C₂₀H₁₁N₅OS |
| Chemical formula | C₂₀H₁₁N₅OS |
| Reversible | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | TOPK/PBK |
| Primary Target IC<sub>50</sub> | 2 µM |
| Purity | ≥ 98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 614849-5MGCN | 04055977186338 |
Documentation
TOPK/PBK Inhibitor, HI-TOPK-032 - CAS 487020-03-1 - Calbiochem SDS
| Title |
|---|
TOPK/PBK Inhibitor, HI-TOPK-032 - CAS 487020-03-1 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 614849 |
References
| Reference overview |
|---|
| Kim, D., et al. 2012, Cancer Res. 72, 3060. |



